Guangxi Hefeng Pharmaceutical

Guangxi Hefeng Pharmaceutical Co., Ltd. is a pharmaceutical manufacturer based in Donglan County, Guangxi, China, with a history dating back to 1970. The company focuses on the production of small molecule drugs, active pharmaceutical ingredients (APIs), and traditional Chinese medicines (TCM). It is notably recognized for its expertise in plant-derived oncology treatments, specifically DNA topoisomerase I inhibitors such as camptothecin and hydroxycamptothecin. Beyond oncology, the company's portfolio includes therapies for Parkinson's disease, analgesics, and various TCM formulations. Guangxi Hefeng operates GMP-certified facilities for various dosage forms, including injections, tablets, and capsules, and serves both domestic and international markets.